Galli, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.827
AS - Asia 2.267
EU - Europa 1.386
SA - Sud America 374
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 44
OC - Oceania 17
Totale 6.974
Nazione #
US - Stati Uniti d'America 2.753
SG - Singapore 715
CN - Cina 609
IT - Italia 556
BR - Brasile 285
HK - Hong Kong 277
VN - Vietnam 263
GB - Regno Unito 167
SE - Svezia 122
BD - Bangladesh 118
FI - Finlandia 104
RU - Federazione Russa 97
KR - Corea 84
DE - Germania 81
FR - Francia 73
NL - Olanda 42
ID - Indonesia 39
AR - Argentina 37
CA - Canada 30
AT - Austria 27
JP - Giappone 25
MX - Messico 25
IN - India 23
IQ - Iraq 20
TR - Turchia 20
BG - Bulgaria 19
PL - Polonia 18
AU - Australia 17
MA - Marocco 17
EC - Ecuador 14
LT - Lituania 12
PK - Pakistan 12
CL - Cile 11
ES - Italia 11
AE - Emirati Arabi Uniti 10
ZA - Sudafrica 9
CO - Colombia 8
IE - Irlanda 8
PT - Portogallo 8
TW - Taiwan 7
EG - Egitto 6
HU - Ungheria 6
KG - Kirghizistan 6
PE - Perù 6
UA - Ucraina 6
VE - Venezuela 6
IL - Israele 5
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
GR - Grecia 4
JM - Giamaica 4
BE - Belgio 3
GT - Guatemala 3
IR - Iran 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JO - Giordania 2
NI - Nicaragua 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 6.914
Città #
Santa Clara 496
Singapore 416
Ashburn 328
Hong Kong 274
Hefei 238
San Jose 220
Chandler 150
Fairfield 145
Ho Chi Minh City 98
London 93
Council Bluffs 92
Helsinki 92
Beijing 88
Nyköping 82
Seoul 82
New York 69
Milan 68
Los Angeles 65
Moscow 49
The Dalles 49
Dallas 48
Hanoi 46
Seattle 46
Wilmington 45
Cambridge 41
Bologna 39
Chicago 38
Woodbridge 37
Buffalo 36
Houston 36
Rome 28
Shanghai 28
Jakarta 27
Lauterbourg 26
Princeton 23
São Paulo 23
Modena 22
San Diego 22
Munich 21
Salt Lake City 21
Nuremberg 18
Florence 17
Sofia 17
Ann Arbor 16
Atlanta 15
Kent 15
Tokyo 15
Da Nang 14
Southend 14
Haiphong 13
Rio de Janeiro 13
Boardman 12
Naples 12
Orem 12
Parma 12
Redondo Beach 12
Reggio Emilia 12
Brooklyn 11
Columbus 11
Ankara 10
Louisville 10
Portsmouth 10
Vienna 10
Biên Hòa 9
Elk Grove Village 9
Frankfurt am Main 9
Melbourne 9
Mexico City 9
Bremen 8
Casablanca 8
Des Moines 8
Ksawerów 8
Lappeenranta 8
Porto Alegre 8
Warsaw 8
Bari 7
Brasília 7
Dearborn 7
Dublin 7
North Bergen 7
Padova 7
Amsterdam 6
Cagliari 6
Chennai 6
Dhaka 6
Lahore 6
Montreal 6
Palermo 6
Paris 6
Quito 6
Santiago 6
Shijiazhuang 6
Tampa 6
Thái Bình 6
Toronto 6
Treviso 6
Trieste 6
Waltham 6
Baghdad 5
Bergamo 5
Totale 4.403
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 338
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 290
EULAR guidelines on ANCA-associated vasculitis in the real life 272
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 250
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 232
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 230
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 227
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 215
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 201
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 196
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 189
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 187
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 185
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 183
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 178
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 173
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 172
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 165
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 164
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 163
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 157
Development of the Takayasu Arteritis Integrated Disease Activity Index 154
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 154
What to Know About Biopsy Sampling and Pathology in Vasculitis? 153
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 147
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 145
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 144
The management of large vessel vasculitides 142
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 140
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 137
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 137
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 129
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 124
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 123
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 122
Reply 117
Current management of giant cell arteritis and its complications 117
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 81
Totale 6.974
Categoria #
all - tutte 30.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 18 44 18 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20263.324 264 188 295 401 357 203 388 172 371 238 251 196
2026/2027136 123 13 0 0 0 0 0 0 0 0 0 0
Totale 6.974